Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00231569 · ClinicalTrials.gov registry record · Phase 2
Dose-escalating Safety Study in Subjects on Stable Statin Therapy
A Phase 2 study, sponsored by Kastle Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT00231569: Completed Phase 2 study, sponsored by Kastle Therapeutics.
NCT00231569 is a Phase 2 study that has completed, run by Kastle Therapeutics. The registered enrollment target is 74 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00231569, a Phase 2 study, has completed, sponsored by Kastle Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.
Interventions
- DRUG ISIS 301012 or Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00231569 record still lists
NCT00231569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 1 intervention - of which ISIS 301012 or Placebo is the first listed.
NCT00231569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00231569 about?
NCT00231569 is a clinical study titled "Dose-escalating Safety Study in Subjects on Stable Statin Therapy". The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.
What is the current status of trial NCT00231569?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2005-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00231569?
The interventions under investigation include: ISIS 301012 or Placebo (DRUG).
Who is sponsoring clinical trial NCT00231569?
This trial is sponsored by Kastle Therapeutics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00231569's enrollment target sits among peer trials
74 920th of 2000 higher than 1,077 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia